Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
Identifieur interne : 002B52 ( Main/Exploration ); précédent : 002B51; suivant : 002B53Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
Auteurs : Yoshiaki Furukawa [Canada]Source :
- Advances in neurology [ 0091-3952 ] ; 2004.
English descriptors
- KwdEn :
- Antiparkinson Agents (therapeutic use), Brain Chemistry, Dystonia (classification), Dystonia (complications), Dystonia (drug therapy), Dystonia (genetics), Family Health, GTP Cyclohydrolase (deficiency), GTP Cyclohydrolase (genetics), Genetic Heterogeneity, Genetic Linkage, Humans, Levodopa (therapeutic use), Motor Activity, Mutation, Parkinson Disease, Secondary (complications), Parkinson Disease, Secondary (genetics), Phenylketonurias (etiology), Phenylketonurias (genetics), Tyrosine 3-Monooxygenase (genetics).
- MESH :
- chemical , deficiency : GTP Cyclohydrolase.
- chemical , genetics : GTP Cyclohydrolase, Tyrosine 3-Monooxygenase.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- classification : Dystonia.
- complications : Dystonia, Parkinson Disease, Secondary.
- drug therapy : Dystonia.
- etiology : Phenylketonurias.
- genetics : Dystonia, Parkinson Disease, Secondary, Phenylketonurias.
- Brain Chemistry, Family Health, Genetic Heterogeneity, Genetic Linkage, Humans, Motor Activity, Mutation.
PubMed: 14509665
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001377
- to stream PubMed, to step Curation: 001377
- to stream PubMed, to step Checkpoint: 001377
- to stream Ncbi, to step Merge: 000354
- to stream Ncbi, to step Curation: 000354
- to stream Ncbi, to step Checkpoint: 000354
- to stream Main, to step Merge: 002E96
- to stream Main, to step Curation: 002B52
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.</title><author><name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name><affiliation wicri:level="1"><nlm:affiliation>Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:14509665</idno><idno type="pmid">14509665</idno><idno type="wicri:Area/PubMed/Corpus">001377</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001377</idno><idno type="wicri:Area/PubMed/Curation">001377</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001377</idno><idno type="wicri:Area/PubMed/Checkpoint">001377</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001377</idno><idno type="wicri:Area/Ncbi/Merge">000354</idno><idno type="wicri:Area/Ncbi/Curation">000354</idno><idno type="wicri:Area/Ncbi/Checkpoint">000354</idno><idno type="wicri:doubleKey">0091-3952:2004:Furukawa Y:update:on:dopa</idno><idno type="wicri:Area/Main/Merge">002E96</idno><idno type="wicri:Area/Main/Curation">002B52</idno><idno type="wicri:Area/Main/Exploration">002B52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.</title><author><name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name><affiliation wicri:level="1"><nlm:affiliation>Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><series><title level="j">Advances in neurology</title><idno type="ISSN">0091-3952</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term><term>Brain Chemistry</term><term>Dystonia (classification)</term><term>Dystonia (complications)</term><term>Dystonia (drug therapy)</term><term>Dystonia (genetics)</term><term>Family Health</term><term>GTP Cyclohydrolase (deficiency)</term><term>GTP Cyclohydrolase (genetics)</term><term>Genetic Heterogeneity</term><term>Genetic Linkage</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Motor Activity</term><term>Mutation</term><term>Parkinson Disease, Secondary (complications)</term><term>Parkinson Disease, Secondary (genetics)</term><term>Phenylketonurias (etiology)</term><term>Phenylketonurias (genetics)</term><term>Tyrosine 3-Monooxygenase (genetics)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en"><term>GTP Cyclohydrolase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>GTP Cyclohydrolase</term><term>Tyrosine 3-Monooxygenase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Dystonia</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Dystonia</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Phenylketonurias</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Dystonia</term><term>Parkinson Disease, Secondary</term><term>Phenylketonurias</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Brain Chemistry</term><term>Family Health</term><term>Genetic Heterogeneity</term><term>Genetic Linkage</term><term>Humans</term><term>Motor Activity</term><term>Mutation</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:14509665
|texte= Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:14509665" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |